Search results
Results from the WOW.Com Content Network
The Carl R. Woese Institute for Genomic Biology (IGB) is an interdisciplinary facility for genomics research at the University of Illinois Urbana-Champaign. The Institute was built in 2006 to centralize biotechnology research at the University of Illinois. Current research at the IGB explores the genomic bases of a wide range of phenomena ...
pgEd develops tools for teachers and general audiences that examine the potential benefits and risks of personalized genome analysis. These include freely accessible, interactive lesson plans that tackle issues such as genetic testing of minors, reproductive genetics, complex human traits and genetics, and the history of eugenics.
National Human Genome Research Institute; USC Institute Of Translational Genomics; Massachusetts. Broad Institute (Massachusetts Institute of Technology and Harvard University) Dana–Farber Cancer Institute; Whitehead Institute for Biomedical Research (Massachusetts Institute of Technology) Missouri. McDonnell Genome Institute (Washington ...
Van Andel Institute (VAI) is a 501(c)(3) nonprofit biomedical research and science education organization in Grand Rapids, Michigan. VAI was founded by Jay and Betty Van Andel in 1996. [1] The institute's research focuses on cancer epigenetics and Parkinson's disease. Its educational efforts support teacher development and science education ...
ACEGID's research focusses on the use of advanced genomics tools and techniques for investigating infectious diseases, performing surveillance, developing diagnostics, drugs and vaccines, and providing information needed by public health institutions for evidence-based policy-making.
The institute’s primary goal is to improve patient care through the use of gene, cell and nucleotide therapies. To achieve this goal, the Institute is formed of a cross-disciplinary mix of clinicians and scientists that include physicians treating patients with novel gene therapies in the Mount Sinai Health System, biologists developing and testing new drugs and drug platforms, and data ...
The formation of the IGI was initially announced in March 2014 as the "Innovative Genomics Initiative", a partnership between UC Berkeley and UCSF researchers and biopharmaceutical industry partners with the aim of enhancing and genome-editing technology and applying it to drug development and global health, with funding support from the Li Ka ...
The institute was the result of consolidating four organizations: the Center for the Advancement of Genomics, The Institute for Genomic Research (TIGR), the Institute for Biological Energy Alternatives, and the J. Craig Venter Science Foundation Joint Technology Center. It has facilities in Rockville, Maryland, and San Diego, California.